|
|
|
|
|
Delaware
|
001-32209
|
47-0937650
|
||
(State
or other jurisdiction
|
|
(Commission
File Number)
|
|
(IRS
Employer
|
of
incorporation)
|
|
|
|
Identification
No.)
|
8725
Henderson Road, Renaissance One
|
|
|
Tampa,
Florida
|
|
33634
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Medicare
membership as of March 31, 2006
|
||
MA
(includes MA-only and MA-PD plans)
|
74,000
|
|
PDP
|
703,500
|
· |
the
potential expiration, cancellation or suspension of our state or federal
contracts;
|
· |
our
lack of prior operating history, including lack of experience with
network
providers and health benefits management, in expansion markets, including
Georgia;
|
· |
our
lack of prior operating history in the prescription drug plan (“PDP”)
business and potential inability to accurately predict the number of
members in our PDP plans, including those who enroll through affirmative
choice as well as through
auto-assignment;
|
· |
our
ability to accurately predict and effectively manage health benefits,
drug
costs and other operating expenses;
|
· |
the
potential for confusion in the marketplace concerning PDP programs
resulting from, among other things, the proliferation of health care
options facing Medicare beneficiaries and the complexity of the PDP
offerings, including the benefit
structures;
|
· |
our
ability to accurately estimate incurred but not reported medical
costs;
|
· |
risks
associated with future changes in healthcare laws, including repeal
or
modification of the Medicare Modernization Act of 2003 or any portion
thereof;
|
· |
potential
reductions in funding for government healthcare programs, including
reductions in funding resulting from the escalating costs of prescription
drugs;
|
· |
risks
associated with periodic government reimbursement rate adjustments,
the
timing of the CMS risk-corridor payments to PDP providers and the
accounting treatment for the PDP
programs;
|
· |
our
ability to develop processes and systems to support our operations
and
future growth;
|
· |
regulatory
changes and developments, including potential marketing restrictions
or
sanctions and premium recoupment;
|
· |
potential
fines, penalties or operating restrictions resulting from regulatory
audits, examinations, investigations or other
inquiries;
|
· |
risks
associated with our acquisition strategy;
|
· |
risks
associated with our efforts to expand into additional states and
counties;
|
· |
risks
associated with our substantial debt obligations;
and
|
· |
risks
associated with our rapid growth, including our ability to attract
and
retain qualified management personnel.
|
Date:
April 28, 2006
|
WELLCARE
HEALTH PLANS, INC.
/s/
THADDEUS BEREDAY
Thaddeus
Bereday
Senior
Vice President and General Counsel
|